AMN HEALTHCARE SERVICES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.24 USD | -0.78% |
|
-4.16% | -24.89% |
| Sales 2024 * | 2.98B 4.07B | Sales 2025 * | 3.01B 4.11B | Capitalization | 2.14B 2.92B |
|---|---|---|---|---|---|
| Net income 2024 * | 50M 68.3M | Net income 2025 * | 86M 117M | EV / Sales 2024 * | 1.05 x |
| Net Debt 2024 * | 979M 1.34B | Net Debt 2025 * | 856M 1.17B | EV / Sales 2025 * | 1 x |
| P/E ratio 2024 * |
42.3
x | P/E ratio 2025 * |
27.9
x | Employees | 3,585 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.53% |
More Fundamentals
* Assessed data
More news
Latest transcript on AMN Healthcare Services, Inc.
More recommendations
More press releases
| 1 day | -0.78% | ||
| 1 week | -4.16% | ||
| Current month | -6.24% | ||
| 1 month | -1.66% | ||
| 3 months | +2.53% | ||
| 6 months | -16.61% | ||
| Current year | -24.89% |
1 week
55.49
59.96
1 month
53.0063.43
Current year
53.0080.22
1 year
53.00112.44
3 years
53.00129.12
5 years
36.65129.12
10 years
10.95129.12
| Managers | Title | Age | Since |
|---|---|---|---|
Caroline Grace
CEO | Chief Executive Officer | 55 | 22-11-27 |
Jeffrey Knudson
DFI | Director of Finance/CFO | 49 | 21-11-07 |
Mark Hagan
CTO | Chief Tech/Sci/R&D Officer | 55 | 18-07-04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Douglas Clark
CHM | Chairman | 73 | 99-10-31 |
Mark Foletta
BRD | Director/Board Member | 63 | 12-12-11 |
Jeff Harris
BRD | Director/Board Member | 69 | 05-08-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.34% | 375 M€ | +8.78% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 56.24 | -0.78% | 387,014 |
| 24-05-23 | 56.68 | -0.63% | 493,047 |
| 24-05-22 | 57.04 | +2.13% | 1,004,895 |
| 24-05-21 | 55.85 | -6.31% | 847,904 |
| 24-05-20 | 59.61 | +1.58% | 672,949 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm
More quotes
AMN Healthcare Services, Inc. is a provider of total talent solutions for healthcare organizations across the United States. The Company provides access to a comprehensive network of quality healthcare professionals through its recruitment strategies and breadth of career opportunities. The Companyâs nurse and allied solutions segment include the Companyâs travel nurse staffing (including international nurse staffing and rapid response nurse staffing), labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing (including revenue cycle solutions) businesses. The physician and leadership solutions segment includes the Companyâs locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement businesses. The technology and workforce solutions segment includes the Companyâs language services, vendor management systems (VMS), workforce optimization, and outsourced solutions businesses.
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
56.24
USD
Average target price
71.25
USD
Spread / Average Target
+26.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.89% | 2.15B | |
| +17.74% | 82.59B | |
| -29.66% | 69.86B | |
| 0.00% | 26.5B | |
| +3.06% | 17.29B | |
| -12.16% | 16.61B | |
| +2.47% | 15.56B | |
| +74.82% | 13.2B | |
| +0.76% | 12.75B | |
| +73.52% | 12.6B |
- Stock Market
- Equities
- AMN Stock
